Industry News
Removing blood clots during PCI not found to improve outcomes
Nov 05, 2013
Results of the TATORT-NSTEMI trial presented at TCT 2013 According to a new study, aspirating blood clots does not significantly reduce microvascular obstruction or reduce the risk of death in patients with non-ST-elevation myocardial infarction (NSTEMI), when compared to standard percutaneous coronary intervention (PCI) without thrombectomy... Read More
Patterns found in cancer's chaos illuminate tumor evolution
Nov 05, 2013
For more than 100 years, researchers have been unable to explain why cancer cells contain abnormal numbers of chromosomes, a phenomenon known as aneuploidy. Many believed aneuploidy was simply a random byproduct of cancer... Read More
In male breast cancer treatment study shows more mastectomy, less radiation than in female disease
Nov 05, 2013
University of Colorado Cancer Center researchers used data from 4,276 cases of male breast cancer and 718,587 cases of female breast cancer to show that the disease is treated differently in men than in women... Read More
Nanotechnology infiltrates and quashes aggressive cancers that survive traditional therapy
Nov 05, 2013
Researchers at Case Western Reserve University have received two grants totaling nearly $1.7 million to build nanoparticles that seek and destroy metastases too small to be detected with current technologies. They are targeting aggressive cancers that persist through traditional chemotherapy and can form new tumors... Read More
Event-free patients following PCI at 1 year may not need prolonged dual antiplatelet therapy
Nov 05, 2013
Results of the ARCTIC-INTERRUPTION trial presented at TCT 2013 According to a new study, patients that do not experience a major cardiac event in the first year after receiving drug-eluting stent (DES) may not need to receive prolonged dual antiplatelet therapy (DAPT)... Read More
Primary HPV screening provides 60 - 70% greater protection against invasive cervical cancer than cytology-based screening
Nov 04, 2013
Primary screening for HPV (Human Papilloma Virus) provides 60 - 70% greater protection against invasive cervical cancer than the cytology-based ('smear-test') screening currently used in most countries where cervical screening is available, according to new results published in The Lancet... Read More
Real-world data confirm clinical value of Bayer's novel oral anticoagulant Xarelto in protecting patients against blood clots
Nov 04, 2013
Data from the real-world XAMOS study just published in the journal Thrombosis and Haemostasis reaffirms the benefits of oral, once-daily Xarelto® (rivaroxaban) in everyday clinical practice to prevent potentially deadly blood clots in adults following major orthopaedic surgery of the hip or knee... Read More
Healthy cell structures assured by protein suicide
Nov 04, 2013
Centrioles are tiny structures in the cell that play an important role in cell division and in the assembly of cilia and flagella. Changes in the number of centrioles are involved in diseases, such as cancer or infertility. Hence, the manipulation of these structures is being discussed for diagnosis and therapeutics... Read More
Study evaluates early stem cell transplants for non-Hodgkin's lymphoma
Nov 04, 2013
Performing early stem cell transplants in patients with aggressive non-Hodgkin's lymphoma does not improve overall survival in high-risk patients, according to a study published in the New England Journal of Medicine. But early transplantation does appear to be beneficial among a small group of patients who are at the very highest risk, the study found... Read More
One HPV vaccine dose 'enough' for cervical cancer prevention
Nov 04, 2013
New research suggests that a single dose of the human papillomavirus vaccine could be enough to protect women against cervical cancer. This is according to a study published in the journal Cancer Prevention Research... Read More
Previous Page Next Page